Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Search

9891 results

  • Article

    Should We Aim Higher? Actively Targeting High-Normal Potassium Levels Reduces Ventricular Arrhythmia Events and Hospitalizations in High-Risk Patients

    • Vitaliy Rotenberg, MD, FACP

    May 1, 2026

    Clinical question: Does a treatment strategy targeting high-normal plasma potassium levels (4.5 to 5.0 mmol/L) reduce the risk of ventricular arrhythmias and cardiovascular events in high-risk...

  • Article

    Antibiotic De-Escalation in Adults Hospitalized for Community- Onset Sepsis Without Evidence of Multidrug-Resistant Infection Is Safe

    • Kanza Qaiser, MD

    May 1, 2026

    Clinical question: In patients hospitalized with community-onset sepsis, does empiric broad-spectrum antibiotic (BSA) de-escalation (on encounter day four), compared with continuation, affect...

  • Article

    Response to Blood Culture Shortage Promotes High Value Care

    • Jenna Carson, MD

    May 1, 2026

    Clinical question: Do diagnostic stewardship interventions in times of crisis lead to sustained change in blood-culture ordering practices? Background: It is estimated that a third of all blood...

  • Article

    Liberal or Restrictive Postoperative Transfusion in Patients at High Cardiac Risk: The TOP Randomized Clinical Trial

    • Aidan Neustadtl, MD

    May 1, 2026

    Clinical question: Does a liberal transfusion strategy decrease the risk of death or major ischemic events after major surgical operations in patients at high risk of cardiac events? Background:...

  • Article

    Predicting Contrast-Associated AKI

    • Maria Mohan, MD, FACP

    May 1, 2026

    Clinical question: Do newer prediction models pooled in a systematic review predict contrast-associated acute kidney injury (CA-AKI)? Background: This systematic review updates a previous evaluation...

  • Article

    Using Biomarkers to Guide Antibiotic Duration in Suspected Sepsis

    • Mandi Abdel Ahad, DO

    May 1, 2026

    Clinical question: Can using daily biomarker-guided protocols, procalcitonin (PCT), or C-reactive protein (CRP) to guide antibiotic duration in adults hospitalized with sepsis safely reduce...

  • Article

    Sodium Bicarbonate Does Not Reduce 90-Day Mortality in Severe Metabolic Acidemia with AKI

    May 1, 2026

    Clinical question: In critically ill adults with severe metabolic acidemia and moderate to severe acute kidney injury (AKI), does intravenous sodium bicarbonate reduce 90-day all-cause...

  • 1
    Article

    The Value of Investing in Good Onboarding for Hospitalists

    • Ruth Jessen Hickman MD

    May 1, 2026

    Every hospital system faces the challenges of orienting and integrating new healthcare personnel, including new hospitalists, many of whom come straight from residency or fellowship. Some bumps are...

  • Article

    Effect of Hydrocortisone on Mortality in Patients with Severe CAP: The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial

    • Rogelio Cruz, MD

    April 9, 2026

    NYU Langone Health Med-Lit Review Clinical Question: In adults admitted to intensive care with severe community-acquired pneumonia (CAP), does treatment with a seven-day course of intravenous...

  • Article

    Aficamten Monotherapy is Superior to Metoprolol Monotherapy for Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy

    • Armaan Hasan, MD

    April 9, 2026

    NYU Langone Health Med-Lit Review Clinical Question: Is aficamten monotherapy superior to metoprolol monotherapy for patients with symptomatic obstructive hypertrophic cardiomyopathy? Background:...

Previous1 2 3 4 … 990Next
Advanced Filters
 - 
Clear All
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • Cookie Preferences